Cancer, Pain, and Immune Therapy: Does Cancer Promote or Inhibit Pain?

Cancer pain is a major health concern, but cancer is not always painful.  Some cancers such as melanoma and early stage cancers before metastasis are not so painful.  Dr. Ji discusses how cancer cells produce PD-L1 (programed death-ligand 1) to mask cancer pain.

Target Audience

Anesthesiologists & CRNAs

Learning Objectives

  • Understand cancer cells can either induce or suppress pain by releasing different mediators 
  • Describe how melanoma cells produce PD-L1 to suppress pain via PD-1 receptor expressed by sensory neurons
  • Discuss how, like chemotherapy, the emerging immune therapy may also cause pain problems
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Registration Opens: 
10/31/2018
Registration Expires: 
02/01/2020
Part of: 
Duke Anesthesiology Commercial Use 2018-2019
Rating: 
0

R. Ji, PhD

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Please login or register to take this course.